Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Net Cash Flow (2018 - 2025)

Historic Net Cash Flow for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to -$8.9 million.

  • Viemed Healthcare's Net Cash Flow fell 45011.81% to -$8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$224000.0, marking a year-over-year decrease of 11765.17%. This contributed to the annual value of $4.7 million for FY2024, which is 21536.2% up from last year.
  • According to the latest figures from Q3 2025, Viemed Healthcare's Net Cash Flow is -$8.9 million, which was down 45011.81% from $9.9 million recorded in Q2 2025.
  • In the past 5 years, Viemed Healthcare's Net Cash Flow ranged from a high of $9.9 million in Q2 2025 and a low of -$13.3 million during Q2 2023
  • Moreover, its 5-year median value for Net Cash Flow was $54000.0 (2021), whereas its average is -$1.0 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first plummeted by 1366666.67% in 2022, then soared by 183972.6% in 2024.
  • Quarter analysis of 5 years shows Viemed Healthcare's Net Cash Flow stood at $1.5 million in 2021, then crashed by 396.17% to -$4.6 million in 2022, then surged by 160.5% to $2.8 million in 2023, then surged by 124.3% to $6.2 million in 2024, then tumbled by 243.6% to -$8.9 million in 2025.
  • Its Net Cash Flow was -$8.9 million in Q3 2025, compared to $9.9 million in Q2 2025 and -$7.4 million in Q1 2025.